skip to Main Content

Vaccines / Preventive Services

Adult immunization rates are falling short of national targets. Learn how global, federal, and state policies affect vaccination uptake. Leverage our findings to guide your strategies. Rely on our expertise commercializing novel and therapeutic vaccines.

Thomas Hess

Considerations for a Shift from Pandemic to Endemic COVID-19 Landscape

Stakeholders in the COVID-19 pandemic response face regulatory and commercial uncertainties as emergency operations transition and market access of products face both emergency use and full licensure.

Self-Administered Vaccines Present Broad Opportunities

The COVID-19 pandemic response has increased investment in vaccine innovations, but also exposed gaps in US and global vaccine access and delivery.

Webinar: Post-Pandemic Planning for Life Sciences Companies

Avalere’s data analytics and market access experts will be joined by Jeff Patton, MD and CEO of OneOncology, to explore critical issues and considerations for life sciences stakeholders following the pandemic.

Amanda Napoles

Updated Analysis Finds Sustained Drop in Routine Vaccines Through 2020

In 2020, the COVID-19 pandemic resulted in nationwide lockdowns and restrictions with a well-documented impact on utilization of routine healthcare services.

Melissa Morley

Accurate COVID-19 Testing to Protect the Military and Support Schools

The US continues to face challenges with managing COVID-19 (SARS-CoV-2) while reopening communities. Accurate COVID-19 diagnostic testing is an effective tool in minimizing the risk of transmission.

Avalere Statement on US Support of TRIPS Waiver for COVID Vaccines

On May 5, the Biden administration announced its support for waiving World Trade Organization (WTO) intellectual property regulations with respect to COVID-19 vaccines, in an effort to increase supply and worldwide access to the vaccines.

The Need for a Centralized Immunization Information System

Immunization Information Systems (IIS), or immunization registries, are used across the US to provide consolidated and complete accounts of patient immunization history in a given city, state, or region.

Christina Badaracco

Strengthening Our Public Health Infrastructure: COVID-19 Lessons

Amid the continuing pandemic and calls for healthcare reform, the new administration seeks to confront the myriad public health issues facing our country today.

mAb Utilization for COVID-19 Remains Low, Despite Availability

Since the beginning of the Public Health Emergency (PHE), manufacturers have been developing monoclonal antibodies (mAbs) and other treatment modalities to prevent and treat COVID-19.

Zachary Klein

Considerations in Ensuring Equitable COVID-19 Vaccine Administration

On January 21, the Biden administration released its National Strategy for the COVID-19 Response and Pandemic Preparedness. The plan highlights numerous actions that the administration intends to implement as it assumes responsibility in the fight against COVID-19.

Shruthi Donthi

How COVID-19 Has Impacted US Adolescent and Adult Vaccine Utilization

Globally and in the US, widespread vaccination has demonstrated medical, economic, and social value to both individuals and public health and has contributed to reductions in morbidity and mortality of certain diseases.

Emily Belowich

Considerations for Employers in the Era of the COVID-19 Vaccine

On December 14, 2020, an intensive care unit nurse in New York was the first American to receive an injection of the COVID-19 vaccine.

John Neal

CMS Takes Steps to Expand Access to COVID-19 Antibody Treatment

The Centers for Medicare & Medicaid Services (CMS) released coding and payment instructions associated with the first physician-administered outpatient COVID-19 therapeutic. The release specifies that during the public health emergency (PHE), Medicare will cover and pay for these infusions in the same way it does for COVID-19 vaccines.

Payer Experiences with COVID-19

New Avalere research featuring payer views of COVID-19 finds a heightened concern about the clinical effectiveness of related future vaccines and therapeutics, a substantial reduction in preventive services due to the COVID-19 public health emergency, and a significant uptick in telehealth adoption.

Christine Liow

Podcast: Designing Pull Funding for a COVID-19 Vaccine

Tune into another episode of Avalere’s Journal Club Review podcast series on Avalere Health Essential Voice. In this segment, our health policy experts discuss a recent study in which a simulation was used to determine whether pull funding could overcome issues related to speed, scaling, and pricing for a COVID-19 vaccine.

Sign up to receive more insights about Vaccines / Preventive Services
Please enter your email address to be notified when new Vaccines / Preventive Services insights are published.

Back To Top